Your browser doesn't support javascript.
loading
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.
van der Heijde, Désirée; Joshi, Avani; Pangan, Aileen L; Chen, Naijun; Betts, Keith; Mittal, Manish; Bao, Yanjun.
Affiliation
  • van der Heijde D; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, mail@dvanderheijde.nl.
  • Joshi A; Health Economics & Outcomes Research.
  • Pangan AL; Immunology Clinical Development, AbbVie Inc., North Chicago, IL and.
  • Chen N; Health Economics & Outcomes Research.
  • Betts K; Analysis Group, Boston, MA, USA.
  • Mittal M; Health Economics & Outcomes Research.
  • Bao Y; Health Economics & Outcomes Research.
Rheumatology (Oxford) ; 55(1): 80-8, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26316575
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Societies, Medical / Magnetic Resonance Imaging / Spondylarthritis / Adalimumab / Motor Activity Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Societies, Medical / Magnetic Resonance Imaging / Spondylarthritis / Adalimumab / Motor Activity Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2016 Type: Article